SRTS241115C9000
- 0.15
- 0.000.00%
Sensus Healthcare Newsroom
Sensus Healthcare Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Sensus Healthcare, Maintains $10 Price Target
Roth MKM Remains a Buy on Sensus Healthcare (SRTS)
Sensus Healthcare Analyst Ratings
HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $10
Maxim Group: Maintains Sensus Healthcare (SRTS.US) rating, adjusted from buy to buy rating, and adjusted target price from $7.00 to $10.00.
Sensus Healthcare Analyst Ratings
Maxim Group Maintains Buy on Sensus Healthcare, Raises Price Target to $10
Sensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy Rating
Analysts Are Bullish on Top Healthcare Stocks: Foghorn Therapeutics (FHTX), Sensus Healthcare (SRTS)
Analysts' Top Healthcare Picks: Sensus Healthcare (SRTS), Inotiv (NOTV)
Buy Rating Affirmed for Sensus Healthcare Amidst Strong Performance and Growth Prospects
Analysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), Outlook Therapeutics (OTLK) and Leap Therapeutics (LPTX)
HC Wainwright & Co. Reiterates Buy on Sensus Healthcare, Maintains $8 Price Target
Sensus Healthcare Analyst Ratings
Promising Growth and Expansion Prospects: A Buy Recommendation for Sensus Healthcare
Analysts' Top Healthcare Picks: Sensus Healthcare (SRTS), Oncolytics Biotech (ONCY)
Analysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), BioLife Solutions (BLFS) and Xeris Pharmaceuticals (XERS)
Sensus Healthcare Analyst Ratings
Maxim Group Sticks to Its Buy Rating for Sensus Healthcare (SRTS)